Read more
2:01 PM · 17 April 2020

BREAKING: Gilead stocks rise amid coronavirus treatment hopes

Gilead Science (GILD.US), a US biotech company gains over 10% at the start of the Wall Street session, based on information about the possible high efficacy of Remdesivir drug for coronavirus. The drug was previously used to treat other viruses, such as Eboli or SARS or MERS. According to the company, the drug is expected to significantly weaken the effect of coronavirus and lead to faster recovery of patients. Attempts to treat people infected with coronavirus with Remdesivir have been conducted on a small sample and involved people with rather mild symptoms, so scientists are asking to refrain from euphoria regarding the effectiveness of this drug. 


Gilead is opening up with a large bullish gap. Source: xStation5

13 February 2026, 6:54 AM

Morning Wrap: Global sell-off in the technology sector (13.02.2026)

12 February 2026, 7:03 PM

Daily summary: Silver plunges 9% 🚨Indices, crypto and precious metals under pressure

12 February 2026, 5:01 PM

US100 loses 1.5% 📉

12 February 2026, 3:40 PM

US Open: Cisco Systems slides 10% after earnings 📉 Mixed sentiments on Wall Street

Join over 2 000 000 XTB Group Clients from around the world
The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits